Holen Sie sich die Stockscreener-App
1.46
2.67%
-0.04
Handel nachbörslich:
1.46
Schlusskurs vom Vortag:
$1.50
Offen:
$1.51
24-Stunden-Volumen:
113.34K
Relative Volume:
0.20
Marktkapitalisierung:
$3.83M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-15.52M
KGV:
-0.0786
EPS:
-18.58
Netto-Cashflow:
$-16.61M
1W Leistung:
-0.68%
1M Leistung:
-59.44%
6M Leistung:
-84.92%
1J Leistung:
-91.41%
1-Tages-Spanne:
$1.43
$1.57
1-Wochen-Bereich:
$1.41
$1.6694
52-Wochen-Spanne:
$1.41
$18.16
Revelation Biosciences Inc Stock (REVB) Company Profile
Firmenname
Revelation Biosciences Inc
Sektor
Branche
Telefon
650-800-3717
Adresse
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
Compare REVB vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
REVB
Revelation Biosciences Inc
|
1.46 | 3.93M | 0 | -15.52M | -16.61M | -18.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Revelation Biosciences Inc Aktie (REVB) Neueste Nachrichten
Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds - Columbia Daily Tribune
Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development - Lubbock Avalanche-Journal
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026) - Peoria Journal Star
Breakout Zone: What are the risks of holding Revelation Biosciences IncJuly 2025 Fed Impact & Fast Entry Momentum Alerts - baoquankhu1.vn
Revelation Biosciences (REVB) Price Target Increased by 300.00% to 86.70 - Nasdaq
Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Victorville Daily Press
Fundamentals Check: What is Graf Global Corp Debt Equity Composite Unitss valuation compared to sectorJuly 2025 Breakouts & AI Driven Price Forecasts - baoquankhu1.vn
Buyback Watch: Is ETHE trading at a discountJuly 2025 Market Mood & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Can Revelation Biosciences Inc. expand into new marketsPortfolio Value Report & Daily Market Momentum Tracking - mfd.ru
Is Revelation Biosciences Inc. Equity Warrant backed by strong institutional buyingWeekly Market Summary & Weekly Return Optimization Alerts - mfd.ru
Revelation Biosciences Raises Capital via Warrant Inducement - TipRanks
Revelation Biosciences Signs Multiple Material Agreements - TradingView
Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026 - Chronicle-Tribune
Will PSIG stock benefit from M AWeekly Market Summary & Growth Oriented Trading Recommendations - baoquankhu1.vn
US Market Recap: Whats the beta of Revelation Biosciences Inc stock2025 Volume Leaders & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
REVB Stock Drops 10% After Company Announces Third Reverse Split In A Year - Asianet Newsable
How Do Investors Really Feel About Revelation Biosciences Inc? - Benzinga
Revelation Biosciences to implement 1-for-4 reverse stock split By Investing.com - Investing.com Nigeria
Revelation Biosciences to Implement 1-for-4 Reverse Stock Split - marketscreener.com
Revelation Biosciences to implement 1-for-4 reverse stock split - Investing.com
Revelation Biosciences to combine 4 shares into 1 for Nasdaq bid - Stock Titan
Finanzdaten der Revelation Biosciences Inc-Aktie (REVB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.24%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):